Pfizer osteoporosis drug gets lukewarm review
Reuters - 30 minutes ago
By Julie Steenhuysen CHICAGO, Feb 24 (Reuters) - Pfizer's (PFE.N) experimental osteoporosis drug lasofoxifene, which is awaiting US regulatory approval, works about as well as currently approved ...
http://bit.ly/djzIss
No comments:
Post a Comment